Tomovircona Gets Provisional ISO Approval as RNAi Virucide for Tobacco Mosaic Virus Control
13 January 2026, Geneva: A new ISO common name has been provisionally approved for an innovative RNA interference (RNAi)-based virucide developed by Silicon Gene Technologies (Shanghai) Co., Ltd. The approval was granted on 9 January 2026 for the product currently identified under the development code SG-001.
The provisionally approved ISO common name is tomovircona, assigned to an RNA (recombinant tobacco mosaic virus coat protein mRNA-specific double-stranded interfering) compound, registered under CAS No. 3052205-09-8.
The molecule represents a new class of targeted antiviral solutions designed to disrupt viral replication through RNA interference mechanisms, marking a significant advancement in plant protection technologies.
Stakeholders are invited to submit objections to the proposed name, particularly in cases where “tomovircona” may conflict with existing trademarks or commercial identifiers. Any such objections must be filed with the ISO Maintenance Agency no later than 9 July 2026. In the absence of objections, tomovircona will be formally approved and incorporated into the next edition of ISO 1750, which will include both preferred names and common names for plant protection products.
Also Read: Brazil Approves 912 Pesticide Registrations in 2025
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
